Attached files
file | filename |
---|---|
10-K - Emmaus Life Sciences, Inc. | v170096_10k.htm |
EX-23.1 - Emmaus Life Sciences, Inc. | v170096_ex23-1.htm |
EX-31.1 - Emmaus Life Sciences, Inc. | v170096_ex31-1.htm |
EX-31.2 - Emmaus Life Sciences, Inc. | v170096_ex31-2.htm |
EX-10.22 - Emmaus Life Sciences, Inc. | v170096_ex10-22.htm |
EX-10.18 - Emmaus Life Sciences, Inc. | v170096_ex10-18.htm |
EX-10.19 - Emmaus Life Sciences, Inc. | v170096_ex10-19.htm |
EX-10.21 - Emmaus Life Sciences, Inc. | v170096_ex10-21.htm |
EX-10.20 - Emmaus Life Sciences, Inc. | v170096_ex10-20.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, in connection with the filing of the Annual Report
on Form 10-K for the year ended September 30, 2009 (the “Report”) by CNS
Response, Inc. (the “Registrant”), the undersigned hereby certifies
that:
|
1.
|
the
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
2.
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Registrant.
|
Date: December
29, 2009
|
/s/ George Carpenter
|
George
Carpenter
|
|
Chief
Executive Officer (Principal Executive and Financial
Officer)
|
A signed
original of this written statement required by Section 906 has been provided to
CNS Response, Inc. and will be retained by CNS Response, Inc. and furnished to
the Securities and Exchange Commission or its staff upon
request.